Expert Review of Anti-Infective Therapy

Papers
(The H4-Index of Expert Review of Anti-Infective Therapy is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a108
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis91
Visceral leishmaniasis elimination in India: progress and the road ahead70
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future64
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review51
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies48
Challenges in preserving antibiotic effectiveness: time for a novel approach43
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin41
Neonatal ocular prophylaxis in the United States: is it still necessary?40
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex40
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia39
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria36
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines35
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR72035
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies30
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’29
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis27
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China27
Treatment of vaginitis caused by non-albicans Candida species26
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies26
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections25
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis24
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges24
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?23
Identifying predictors of treatment failure with community-acquired pneumonia: an update23
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?23
Reemergence of monkeypox: prevention and management23
0.10377597808838